IFI-M · UB Sequential Integration Series

Specimen SS-F-M2-06093 // MULTI-AXIS · IFI-M

UB Sequential Integration Series III-PR-C

Solanum lycopersicum

Tomato

Tier IIIUB Sequential Integration Series

Target Trait

3×

fold-change

Umami+Bitter-Attenuation sequential pathway fold-change

Technical Specifications

SKU

SS-F-M2-06093

Genomic Edits

10

GC Content

46.8%

Construct Length

5,074 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

mGluR1 + TAS2R38 (suppression)

IFI Score

300

Pathway Edits

  • mGluR1 pathway primary gene cluster overexpression for umami axis activation
  • TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
  • Bidirectional promoter system for synchronized U+B dual-axis co-expression
  • Metabolic flux partitioning between IFI-U and IFI-B pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Umami-Bitter-Attenuation combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for U+B simultaneous accumulation
  • Cofactor balance optimization for U+B dual-pathway operation
  • Protein scaffold engineering for U+B enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized mGluR1 and TAS2R38 (suppression) pathway engineeringMetabolic flux partitioning strategy enabling simultaneous umami and bitter-attenuation accumulation without competing pathway suppressionSequential construct stacking for UB multi-axis integrationPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III UB dual-axis sequential integration platform for food ingredient applications requiring verified combined umami+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$1649 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities